SS

Sima Sami Khatib

Director Director DIN 00058072
DIN 00058072 First appointment Feb 1986 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 1986
Shareholding value β€’β€’β€’β€’ Premium profile

About Sima Sami Khatib

Data last updated:

Sima Sami Khatib was a Director at Biogen Laboratories (India) Private Limited (1986–2011) and Director at Medley Laboratories Private Limited (from 1996). The companies operate in Pharma.

DIN 00058072
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 1986
Oldest Company Age 51 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 19861986₹9.2 Lakh (FY 2025)Active
Medley Laboratories Private Limited U24100MH1975PTC018500
Director21 Sep 19961975Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medley Laboratories Private Limited
Biogen Laboratories (India) Private Limited
Premium access

Shareholding and investment profile for Sima Sami Khatib

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sima Sami Khatib

Sima Sami Khatib was first appointed on 27 Feb 1986 as Director at Biogen Laboratories (India) Private Limited. The most recent appointment on record is 21 Sep 1996 at Medley Laboratories Private Limited.

Sima Sami Khatib held 2 earlier board appointments: Biogen Laboratories (India) Private Limited (Director, 27 Feb 1986 to 14 Nov 2011); Medley Laboratories Private Limited (Director, from 21 Sep 1996).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available